- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
Total 2404 results
-
Novartis PharmaceuticalsCompletedColorectal Cancer, Triple Negative Breast Cancer, NSCLC - AdenocarcinomaUnited States, France, Taiwan, Canada, Italy, Singapore, Belgium, Spain, Israel
-
Peptomyc S.L.Active, not recruitingNSCLC | Advanced Solid Tumors | Triple-negative Breast Cancer | CRCSpain
-
National University Hospital, SingaporeRecruitingAdvanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast CancersSingapore
-
Gustave Roussy, Cancer Campus, Grand ParisWithdrawnMetastatic Colorectal Cancer | Triple Negative Breast Cancer | Esophageal Adenocarcinoma | Prostate Adenocarcinoma | Stomach Adenocarcinoma
-
Cantargia ABActive, not recruitingColorectal Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Pancreatic Ductal AdenocarcinomaAustria, Denmark, Germany, Belgium, Spain, Latvia, Netherlands, Lithuania, Estonia, Sweden, Norway
-
Swiss Group for Clinical Cancer ResearchNot yet recruitingTriple-negative Breast Cancer | TNBC - Triple-Negative Breast CancerSwitzerland
-
Peregrine PharmaceuticalsWithdrawnBreast Cancer | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast Cancer | Triple-Negative Breast Neoplasm | ER-Negative PR-Negative HER2-Negative Breast Neoplasms | ER-Negative PR-Negative HER2-Negative Breast Cancer
-
AkesoRecruitingMetastatic Triple-negative Breast Cancer | Locally Advanced Triple-negative Breast CancerChina
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
G1 Therapeutics, Inc.TerminatedBreast Cancer | Breast Neoplasm | Triple-Negative Breast Cancer | Triple-Negative Breast NeoplasmsUnited States, Bulgaria, Croatia, Slovenia, Serbia, Belgium, North Macedonia, Slovakia
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); MedImmune...TerminatedTriple Negative Breast Cancer | Triple Negative Breast Neoplasms | TNBC - Triple-Negative Breast Cancer | Triple-negative Breast CarcinomaUnited States
-
Merck Sharp & Dohme LLCTerminatedNon-small Cell Lung Cancer (NSCLC) | Triple Negative Breast Cancer (TNBC) | NUT Midline Carcinoma (NMC) | Castration-resistant Prostate Cancer (CRPC)
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingNSCLC | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Non Small Cell Lung Cancer Metastatic | NSCLC Stage IV | TNBC - Triple-Negative Breast Cancer | NSCLC Stage IV Without EGFR/ALK MutationUnited States, Canada
-
University of Maryland, BaltimoreSyndax PharmaceuticalsTerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Triple-negative Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Melinda TelliPfizer; BioMarin PharmaceuticalCompletedAdvanced Breast Cancer | HER2/Neu Negative | Triple-Negative Breast CancerUnited States
-
BioNTech SESeventh Framework ProgrammeCompletedBreast Cancer (Triple Negative Breast Cancer (TNBC))Sweden, Germany
-
AmgenRoche-GenentechCompletedMetastatic Colorectal Cancer | Metastatic Triple Negative Breast CancerUnited States, Belgium, Spain, Australia, Switzerland, Germany
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Susan G. Komen Breast Cancer FoundationCompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Fudan UniversityNot yet recruitingTriple-negative Breast Cancer
-
UNICANCERSOLTI Breast Cancer Research Group; Vall d'Hebron Institute of Oncology; MSD...Not yet recruitingTriple-negative Breast Cancer
-
Shanghai Jiao Tong University School of MedicineCSPC Ouyi Pharmaceutical Co., Ltd.; Innovent Biologics, Inc.Not yet recruiting
-
Fudan UniversityNot yet recruiting
-
Chipscreen Biosciences, Ltd.RecruitingTriple-negative Breast CancerChina
-
AHS Cancer Control AlbertaNot yet recruitingBreast Cancer Triple NegativeCanada
-
Fudan UniversityRecruitingTriple-negative Breast CancerChina
-
Fudan UniversityRecruitingTriple-negative Breast CancerChina
-
University of Kansas Medical CenterMerck Sharp & Dohme LLCActive, not recruitingTriple-negative Breast CancerUnited States
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerIsrael, United States, Australia, Korea, Republic of, Belgium, Argentina, Denmark, Finland, Italy, Portugal, Spain, Taiwan, Thailand, Japan, United Kingdom, Brazil, Canada, Colombia, Mexico, France, Costa Rica, Switzerland, Czechia, P... and more
-
SynCore Biotechnology Co., Ltd.Suspended
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerUnited States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
-
Washington University School of MedicineSusan G. Komen Breast Cancer FoundationWithdrawnTriple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast Cancer
-
Taizhou Hanzhong biomedical co. LTDActive, not recruitingTriple-negative Breast CancerChina
-
Washington University School of MedicineSusan G. Komen Breast Cancer FoundationCompletedTriple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast CancerUnited States
-
Fudan UniversityRecruitingTriple-Negative Breast CancerChina
-
First Affiliated Hospital Bengbu Medical CollegeRecruitingTriple-negative Breast CancerChina
-
Sichuan Provincial People's HospitalRecruitingTriple-negative Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingTriple-negative Breast CancerChina
-
Texas Tech University Health Sciences Center, El...RecruitingTriple-negative Breast CancerUnited States
-
Fudan UniversityRecruitingTriple-negative Breast CancerChina
-
Hoffmann-La RocheActive, not recruitingTriple-Negative Breast CancerItaly, Portugal, Slovenia, Spain, Romania, France, Czechia, Peru, Argentina, Chile, Hungary, Mexico, Poland
-
Laura KennedyNational Cancer Institute (NCI)SuspendedBreast Cancer | Triple-negative Breast CancerUnited States
-
Hoffmann-La RocheCompletedTriple-negative Breast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Belgium, Brazil, Germany, Taiwan, Australia, Japan, Spain, Poland, Italy
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdCompletedTriple-negative Breast CancerChina
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...University of Milan; European Institute of Oncology; IFOM, The FIRC Institute...Active, not recruitingTriple-negative Breast CancerItaly
-
Guangdong Provincial People's HospitalCompletedTriple-Negative Breast CancerChina
-
Fudan UniversityActive, not recruiting
-
Tianjin Medical University Cancer Institute and...UnknownTriple-negative Breast CancerChina
-
Arbeitsgemeinschaft medikamentoese TumortherapieTakedaTerminatedTriple-Negative Breast CancerAustria
-
Fudan UniversityNot yet recruitingTriple-negative Breast Cancer